Latest Geographic Expansion News

Starpharma reports a $1.37 million profit for H1 FY26, driven by a major upfront payment from Genentech and progress in its radiopharmaceutical pipeline. The biotech also expands its consumer health footprint amid growing partnerships.

Simonds Group Limited has reported a robust 1H FY26 performance with a 14% revenue increase and strategic entry into Western Australia, signalling confidence in sustained growth.

GQG Partners Inc. reported a 6.3% increase in net revenue and a 7.3% rise in net profit for 2025, alongside a strategic US ETF launch and a new dividend declaration.

Breville Group Limited has reported a record half-year revenue of AUD 1.1 billion, overcoming US tariff challenges through strategic manufacturing shifts and robust product innovation. The company’s steady profitability and geographic expansion signal a confident growth trajectory.

Breville Group Limited has reported a record half-year revenue of $1.1 billion for the six months ended December 2025, alongside modest profit growth and a raised interim dividend.

CSL Limited has released its half-year results showing a slight revenue decline amid ongoing transformation efforts, while maintaining its full-year guidance and expanding its share buyback program.

Amotiv Limited reported a 3.3% revenue increase to $520.5 million for the half year ended December 2025, alongside a 39.4% jump in net profit, driven by new business wins and operational efficiencies despite margin pressures in key segments.

ResMed Inc. reported robust financial results for Q2 FY2026, driven by strong demand in its Sleep and Breathing Health and Residential Care Software segments. The company also navigates ongoing patent litigation while maintaining solid liquidity and shareholder returns.

Synertec Corporation Limited has reported a robust 25% increase in revenue for FY26 Q2 alongside a significant turnaround to positive operating cashflow, underpinned by strong project pipelines and strategic partnerships.

Telix Pharmaceuticals has achieved a key milestone with China’s NMPA accepting its New Drug Application for Illuccix, a prostate cancer imaging agent backed by strong Phase 3 data. This paves the way for Telix to enter a rapidly growing Chinese market alongside its global approvals.

Love Group Global Ltd has reported record operating profits in Q2 FY26, driven by growth in Hong Kong and marketing efficiencies, while planning to expand its matchmaking services into new international markets.

Symal Group has agreed to acquire an 80% stake in South Australian civil contractor Davison Earthmovers for $23.2 million, marking a strategic entry into a region with a booming infrastructure pipeline.